Andorra vs Montenegro: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Andorra
- Montenegro
How they compare
Montenegro currently reports 37.2% against 35.5% in Andorra, a difference of 1.7%.
Across all 9 years both countries report, Montenegro has been ahead every year.
Andorra ranks 12th and Montenegro ranks 10th of 166 countries.
Montenegro has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.7% | 36.7% | 0.9% | Montenegro |
| 2010s | 35.4% | 36.5% | 1.1% | Montenegro |
| 2020s | 35.4% | 37.1% | 1.7% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Andorra or Montenegro?
- Montenegro, at 37.2% against 35.5% in Andorra as of 2024.
- What is the difference in prevalence of current tobacco use between Andorra and Montenegro?
- 1.7%, with Montenegro ahead.
- How many years of comparable data are there for Andorra and Montenegro?
- 9 years are reported by both, from 2000 to 2024.
- How do Andorra and Montenegro rank globally for prevalence of current tobacco use?
- Andorra ranks 12th and Montenegro ranks 10th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.